共 211 条
[1]
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]
Bray F(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 908-943
[3]
Center MM(2002)Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739
[4]
Ferlay J(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164-1171
[5]
Ward E(2014)Transarterial chemoembolization and radioembolization Semin Liver Dis 34 435-443
[6]
Forman D(2015)Hepatocellular carcinoma: from clinical practice to evidence-based treatment protocols World J Hepatol 7 2274-2291
[7]
Llovet JM(2006)Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver Semin Intervent Radiol 23 64-72
[8]
Real MI(2014)Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization Int J Radiat Oncol Biol Phys 88 1025-1031
[9]
Montana X(2007)Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 13-23
[10]
Lo CM(2004)Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients Liver Transplant 10 S107-S110